Patents by Inventor Patricia Ovaert

Patricia Ovaert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200016155
    Abstract: The invention relates to novel compositions including an aldosterone antagonist and administered according to a predetermined dosage for treating heart deficiency in non-human mammals.
    Type: Application
    Filed: September 20, 2019
    Publication date: January 16, 2020
    Inventors: Patricia OVAERT, Florence BERNAY, Jerome GUYONNET
  • Publication number: 20160175328
    Abstract: The invention relates to new compositions comprising an aldosterone antagonist according to a particular posology for the treatment of heart failure in non-human mammal animals.
    Type: Application
    Filed: January 13, 2016
    Publication date: June 23, 2016
    Inventors: Patricia Ovaert, Florence Bernay, Jerome Guyonnet
  • Publication number: 20100183718
    Abstract: The invention relates to novel compositions including an aldosterone antagonist and administered according to a predetermined dosage for treating heart deficiency in non-human mammals.
    Type: Application
    Filed: June 25, 2008
    Publication date: July 22, 2010
    Applicant: CEVA SANTE ANIMALE SA
    Inventors: Patricia Ovaert, Florence Bernay, Jerome Guyonnet
  • Publication number: 20090270356
    Abstract: The invention relates to new compositions comprising an aldosterone antagonist according to a particular posology for the treatment of heart failure in non-human mammal animals.
    Type: Application
    Filed: April 28, 2009
    Publication date: October 29, 2009
    Applicant: CEVA SANTE ANIMALE SA
    Inventors: Patricia Ovaert, Florence Bernay, Jerome Guyonnet
  • Patent number: 5648087
    Abstract: The present invention relates to an anaesthetic veterinary pharmaceutical composition, comprising a general anaesthetic selected from phencyclidine derivatives such as ketamine or tiletamine, as well as 0.015 to 1.25 molar equivalents of selegiline, combined in a single pharmaceutical composition or presented separately.
    Type: Grant
    Filed: March 4, 1994
    Date of Patent: July 15, 1997
    Assignee: Sanofi Sante Nutrition Animale
    Inventors: Patricia Ovaert, Eliane Boivin